Vascugenix
Vascugenix: Innovating cardiovascular procedures with advanced medical devices like Speed-Torque.
Founded
2016Vascugenix: Innovating cardiovascular procedures with advanced medical devices like Speed-Torque.
Founded with a mission to revolutionize cardiovascular procedures, Vascugenix is a medical device company dedicated to developing innovative products that enhance interventional cardiovascular treatments. Their flagship product, Speed-Torque, is designed to optimize guidewire manipulation during Percutaneous Coronary and Peripheral Artery interventions. This device aims to provide physicians with greater accuracy, speed, and control, ultimately improving patient outcomes. Vascugenix primarily targets the cardiovascular medical market, focusing on both coronary and peripheral artery procedures.
Notable figures associated with Vascugenix include key medical professionals and industry experts who contribute to the company's innovative edge. The company has garnered attention from investors interested in advancing medical technology. Among its key achievements, the development and successful implementation of Speed-Torque stand out, showcasing Vascugenix's commitment to improving procedural efficiency and patient care. The overall impact of Vascugenix lies in its potential to significantly enhance the precision and effectiveness of cardiovascular interventions, thereby setting new standards in the medical device industry.
Companies similar to Vascugenix include Scientia Vascular, Cagent Vascular, Traverse Vascular and CircumFix Solutions.
Vascugenix was founded in 2016.
Vascugenix's headquarters is located in Little Rock, AR, US.
Vascugenix's most recent funding round was for $100k (USD) in May 2021.
As of May 1, 2021, Vascugenix has disclosed funding of $545k (USD). Undisclosed round amounts are excluded.
Vascugenix has 3 employees as of Feb 5, 2024.
CircumFix Solutions
